RAP 0.00% 20.5¢ resapp health limited

Ann: Update on US FDA De Novo Classification Request, page-64

  1. 26,698 Posts.
    lightbulb Created with Sketch. 1732
    I think this will settle at 10c in a few days and then it will be a slow grind back to 20c with the other clinical trial results. Interestingly, it has dropped more than the 1st failed US clinical trial but in a much better position, possibly as most of the SI are dumping those shares.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.